Immuno Cancer Biotherapeutics, Inc.
One private offering reported to the SEC on Form D since 2016, $75K sold in all. Biotech, South Dakota.
- Form D offerings: 1
- Reported sold: $75K
- Newest: Oct 15, 2026
Newest first; an amended notice updates the amount sold. Each filing opens on EDGAR.
| Filed | Round | Sold | Offering | Filed as | Last amended | Filing |
|---|---|---|---|---|---|---|
| Oct 15, 2026 | โ | $75K | Open-ended | Immuno Cancer Biotherapeutics, Inc.Biotech ยท South Dakota | Not amended | 0002158173-26-000001 |
- Business address
- Canton, SD
- Incorporated in
- Delaware
- All SEC filings
- CIK 2158173 on EDGAR
A Form D reports the amount offered and sold so far in a private offering, not who invested or at what valuation. Shares issued in a merger are left out. The profile is read from EDGAR daily. SEC Form D data sets and EDGAR